Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: Considerations for study conduct and endpoint determination

Alexandra Lansky; Tayyab Shah; William Wijns; Giulio G. Stefanini; Andrew Farb; Aaron Kaplan; Bo Xu; Cody Pietras; Eric Velazquez; Patrick Serruys; Felix Mahfoud; Andreas Baumbach

doi:10.4244/EIJV16I10A147

Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: Considerations for study conduct and endpoint determination

Alexandra Lansky
, Tayyab Shah
, William Wijns
, Giulio G. Stefanini
, Andrew Farb
, Aaron Kaplan
, Bo Xu
, Cody Pietras
, Eric Velazquez
, Patrick Serruys
, Felix Mahfoud
, Andreas Baumbach

Yale University School of Medicine
Queen Mary University of London
Galway University Hospital
Humanitas Research Hospital
Center for Drug Evaluation and Research
Dartmouth-Hitchcock Medical Center
Chinese Academy of Medical Sciences
Universitätsklinikum des Saarlandes Medizinische Fakultät der Universität des Saarlandes
Massachusetts Institute of Technology

Research output: Contribution to a Journal (Peer & Non Peer) › Review article › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	787-793
Number of pages	7
Journal	EuroIntervention
Volume	16
Issue number	10
DOIs	https://doi.org/10.4244/EIJV16I10A147
Publication status	Published - Nov 2020
Externally published	Yes

Access to Document

10.4244/EIJV16I10A147

Cite this

Lansky, A., Shah, T., Wijns, W., Stefanini, G. G., Farb, A., Kaplan, A., Xu, B., Pietras, C., Velazquez, E., Serruys, P., Mahfoud, F., & Baumbach, A. (2020). Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: Considerations for study conduct and endpoint determination. EuroIntervention, 16(10), 787-793. https://doi.org/10.4244/EIJV16I10A147

@article{06669c7c6dd2443abe5aeb0be8443c54,

title = "Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: Considerations for study conduct and endpoint determination",

author = "Alexandra Lansky and Tayyab Shah and William Wijns and Stefanini, \{Giulio G.\} and Andrew Farb and Aaron Kaplan and Bo Xu and Cody Pietras and Eric Velazquez and Patrick Serruys and Felix Mahfoud and Andreas Baumbach",

year = "2020",

month = nov,

doi = "10.4244/EIJV16I10A147",

language = "English",

volume = "16",

pages = "787--793",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "Europa Group",

number = "10",

}

Lansky, A, Shah, T, Wijns, W, Stefanini, GG, Farb, A, Kaplan, A, Xu, B, Pietras, C, Velazquez, E, Serruys, P, Mahfoud, F & Baumbach, A 2020, 'Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: Considerations for study conduct and endpoint determination', EuroIntervention, vol. 16, no. 10, pp. 787-793. https://doi.org/10.4244/EIJV16I10A147

TY - JOUR

T1 - Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials

T2 - Considerations for study conduct and endpoint determination

AU - Lansky, Alexandra

AU - Shah, Tayyab

AU - Wijns, William

AU - Stefanini, Giulio G.

AU - Farb, Andrew

AU - Kaplan, Aaron

AU - Xu, Bo

AU - Pietras, Cody

AU - Velazquez, Eric

AU - Serruys, Patrick

AU - Mahfoud, Felix

AU - Baumbach, Andreas

PY - 2020/11

Y1 - 2020/11

UR - https://www.scopus.com/pages/publications/85096814782

U2 - 10.4244/EIJV16I10A147

DO - 10.4244/EIJV16I10A147

M3 - Review article

C2 - 33215993

AN - SCOPUS:85096814782

SN - 1774-024X

VL - 16

SP - 787

EP - 793

JO - EuroIntervention

JF - EuroIntervention

IS - 10

ER -

Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: Considerations for study conduct and endpoint determination

Access to Document

Other files and links

Cite this